Business Context and Reporting Period
Company: Alterity Therapeutics Limited (a development stage enterprise)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of July 2025
Date Filed: July 21, 2025
Principal Executive Office: Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. As a development stage enterprise, the document focuses on regulatory filings rather than financial performance data.
Material Changes
No material financial changes versus a prior comparable period are disclosed in this filing. The document serves primarily to incorporate exhibits by reference into existing registration statements.
Guidance, Outlook, and Unusual Items
Exhibits Submitted: Exhibit 99.1 contains an "Application for quotation of securities - ATH".
Registration Statements: This Form 6-K is incorporated by reference into Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417, 333-250076).
Management Commentary: No specific outlook or commentary is provided in the text of this filing.
Investor Verification Checklist
- Verify the status and outcome of the "Application for quotation of securities - ATH" referenced in Exhibit 99.1.
- Review the referenced Form S-8 and Form F-3 registration statements for details on capital raising activities.
- Confirm the company's current cash runway and burn rate, as this filing does not disclose financial position.
- Monitor for subsequent filings that may contain the financial results for the period ending July 2025.